gastrointestinal cancer

DESCRIPTION

Treatment for gastrointestinal (GI) tumors often requires a combination of Radiation therapy, chemotherapy and surgery, which can be difficult for patients to tolerate due to the proximity of many important abdominal organs. In some cases, conventional Radiotherapy is not even an option because of the high risk of damaging surrounding healthy tissues.

The progresses regarding the diagnosis and the treatment of gastrointestinal and pancreatic neuroendocrine tumors (NETs) widely opened the doors for more trials and protocols based on Radiotheranostics treatments for GI tumors.

Sources: Research Gate, IBA

gastrointestinal

APPROVED TREATMENTS

32P-OncoSil (pancreas cancer)

IN DEVELOPMENT

177Lu-IPN-01087 (pancreas cancer)

177Lu-MVT-1075 (pancreas cancer)

188Re-P2045 (Tozaride) (pancreas cancer)

224Ra-RadSpherin (colorectal cancer)

225Ac-Lintuzumab (225Ac-Actimab-A™) (colorectal cancer)

MORE ABOUT GASTROINTESTINAL CANCER

Gastrointestinal Cancers – American College of Gastroenterology

Tumours Gastrointestinal – European Organisation for Research and Treatment of Cancer (EORTC)

Compassionate Use Program (CUP)

CUP enables patients with life-threatening diseases, such as advanced cancer, to resort to experimental treatments when standard anti-cancer solutions and access to clinical trials are not an option. Access to CUP programs depends on local regulations and can vary from one treatment to another.

Ask your referring physicians for more information regarding CUP.

physicians